Home > News > pSivida Requires Some Patience
April 17th, 2005
pSivida Requires Some Patience
Jack Uldrich: Lately, I have received a few emails questioning pSivida's recent poor stock performance. They are excellent questions and I'll admit that I, too, have been surprised by pSivida's 35 percent dive over the past two months.
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014